Advertisement
Screener

OS THERAPIES INCORPORATED (OSTX) Form D

OS THERAPIES INCORPORATED Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2026-03-06: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2026-03-04; Total offering amount $2,000,000.
  • 2026-01-20: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2026-01-14; Total offering amount $7,531,884.
  • 2025-09-10: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-09-02; Total offering amount $3,777,808.
  • 2025-07-16: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-06-23; Total offering amount $4,216,794.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2026-03-06Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired2026-03-04$2,000,000$2,000,000$09
2026-01-20Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2026-01-14$7,531,884$3,498,650$4,033,2349
2025-09-10Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-09-02$3,777,808$3,777,808$010
2025-07-16Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-06-23$4,216,794$4,216,794$027
2025-01-22Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-12-31$10,000,000$7,103,000$2,897,00034
2023-12-14Rule 506(b)Unsecured Convertible Promissory Note and Restricted Stock Grant for shares of Class A Common Stock.2023-12-08$2,000,000$700,000$1,300,0003
2023-01-11Rule 506(b)Equity; OptionToAcquire; Convertible promissory notes including underlying Class A common stock issuable upon conversion of such notes.2022-11-16$2,000,000$2,000,000$011
2020-05-01Rule 506(b)Debt; Convertible DebtYet to occur$5,000,000$0$5,000,0000
2019-12-05Rule 506(b)Convertible debt2018-07-25$500,000$359,000$141,00011

Similar stocks

Stock NameCountryMarket CapPE Ratio
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
iBio, Inc. (IBIO)United States$0.077B-2.94
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40